Mercy Hospital of Philadelphia

Philadelphia, Pennsylvania 19143

0 studies enrolling now · 7 studies all time

What they study most

Breast Cancer, Breast Carcinoma, Breast Ductal Carcinoma In Situ, HER2/Neu Positive, Node Positive HER2 Negative Breast Cancer, Progesterone Receptor Positive, Recurrent Breast Carcinoma, Recurrent Large Cell Lung Carcinoma, Recurrent Lung Adenocarcinoma, Recurrent Squamous Cell Lung Carcinoma, Stage IA Breast Cancer AJCC v7, Stage IB Breast Cancer AJCC v7

Studies at this site

• Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery — Completed
• Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer — Completed
• Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy — Completed
• Breast Cancer WEight Loss Study (BWEL Study) — Running, not enrolling
• S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer — Stopped early
• Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy — Stopped early
• Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women — Completed